Drug intelligence / Profile preview

NXT15906F6

Development stage
Unknown
Lead developer
NXT USA
Modality
Small Molecules
Administration
Oral
01

Overview

NXT15906F6 (TamaFlex) is a proprietary botanical combination consisting of standardized extracts from *Tamarindus indica* (tamarind) seeds and *Curcuma longa* (turmeric) rhizomes. It is developed as a synergistic formulation to support joint health and mitigate symptoms of osteoarthritis. Clinical studies have demonstrated that NXT15906F6 significantly reduces knee joint pain and improves musculoskeletal function and joint motility, with effects observed as early as five days after initiation. Its mechanism of action involves anti-inflammatory activity, evidenced by the reduction of systemic inflammatory markers like high-sensitivity C-reactive protein (hs-CRP), and chondroprotective effects, indicated by the reduction of the cartilage degradation marker C-terminal telopeptide of type II collagen (uCTX-II). It is primarily marketed as a dietary supplement for joint comfort and mobility.

Brand names
TamaFlex
Other names
Tamarindus indica seed extract + Curcuma longa rhizome extract
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on NXT15906F6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NXT15906F6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call